Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C)
Наслов
Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C)
Опис
A. Verhaz, Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C), pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779, 2014.
Идентификатор
/unibl/sci/idNaucniRad:17180
Тип
Пронађите сличне уносеArticle
Датум
Библиографски цитат
A. Verhaz, Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C), pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779, 2014
Издавач
pegylated interferon (RO0258310) Roche Clinical Study Report - Protocol MV22255 - Research Report 1060779
Листа аутора
Position: 120100 (9 views)